Necrotizing enterocolitis and hematopoietic cytokines

Clinics in Perinatology

Volumn 27, Issue 3, 2000, Pages 697-716

  Ledbetter, Daniel J ^a   Juul, Sandra E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COLONY STIMULATING FACTOR 1; CYTOKINE; CYTOKINE RECEPTOR; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOKINE; NITRIC OXIDE; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BREAST MILK; CLINICAL FEATURE; DECOMPRESSION; DISEASE COURSE; HUMAN; NECROTIZING ENTEROCOLITIS; NONHUMAN; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0033841202     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70046-4     Document Type: Article

References (134)

1. Prophylactic effect of dietary glutamine supplementation on interleukin-8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis
2. Interleukin-4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells
3. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice
4. Inhibition of acetylcholine induced intestinal motility by interleukin-1 beta in the rat
5. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease
6. Erythropoietin and interleukin-2 activate distinct JAK kinase family members
7. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
8. Is the elimination of endotoxin and cytokines with continuous lavage an alternative procedure in necrotizing enterocolitis?
9. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates
10. Distribution of granulocyte colony-stimulating factor (G-CSF) and G-CSF-receptor mRNA and protein in the human fetus
11. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion
12. Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions
13. Intracolonic release in vivo of interieukin-1 beta in chronic ulcerative colitis
14. Interleukin-1 is a mucus secretagogue
15. Epithelial exposure to hypoxia modulates neutrophil transepithelial migration
16. Regulation of eicosanoid production in rabbit colon by interleukin-1
17. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease
18. Increased interleukin-8 expression in the colon mucosa of patients with inflammatory bowel disease
19. Expression of murine interleukin 11 and its receptor alpha-chain in adult and embryonic tissues
20. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 in eosinophilic gastroenteritis
21. Interleukin-2 modulates intestinal epithelial cell function in vitro
22. Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis
23. Activated eosinophils and interleukin-5 expression in early recurrence of Crohn's disease
24. Concordance of bacterial cultures with endotoxin and interleukin-6 in necrotizing enterocolitis
25. Immunopathologic responses to non-lethal sepsis
26. Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of interleukin-8
27. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis
28. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding
29. Necrotizing enterocolitis
30. Central action of interleukin-1 beta on intestinal motility in rats: Mediation by two mechanisms
31. Alterations in body weight, breaking strength, and wound healing in Wistar rats treated pre- and postoperatively with erythropoietin or granulocyte macrophage-colony stimulating factor: Evidence of a previously unknown anabolic effect of erythropoietin?
32. Necrotizing enterocolitis
33. Clinical use of hematopoietic growth factors in the myelodys-plastic syndromes
34. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance
35. Effects of antimurine interleukin-6 on bacterial translocation during gut-derived sepsis
36. Interleukin-1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC)
37. Preferential enhancement of B cell IgA secretion by intestinal epithelial cell-derived cytokines and interleukin-2
38. Interleukin-1 beta down-regulates collagen and augments collagenase expression in human intestinal smooth muscle cells
39. Corticosteroids repress the interleukin-1 beta-induced secretion of collagenase in human intestinal smooth muscle cells
40. Anti-inflammatory effect of interleukin-10 in rabbit immune complex-induced colitis
41. Complementary organ expression of IL-1 vs. IL-6 and CSF-1 activities in normal and LPS-injected mice
42. High expression of inducible nitric oxide synthase correlates with intestinal inflammation of interleukin-2-deficient mice
43. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis
44. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease
45. The epidemiology of necrotizing enterocolitis infant mortality in the United States
46. Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis
47. Interleukin-1 beta modulation of norepinephrine release from rat myenteric nerves
48. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in inflammatory bowel disease
49. Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease
50. Expression of interleukin-6 by intestinal enterocytes
51. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion
52. Erythropoietin in the neonate
53. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates
54. Why is erythropoietin in mothers milk? Is it enterally absorbed?
55. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus
56. Role of interleukin-1 beta, interleukin-6, and TNF-alpha in intestinal maturation induced by dietary spermine in rats
57. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation
58. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: Evidence for a biological role for IL-8 in inflammation of the colon
59. Interleukin-1 beta induces the expression of interleukin-6 in rat intestinal smooth muscle cells
60. Neonatal necrotizing enterocolitis: Pathogenesis, classification, and spectrum of illness
61. Human milk as a potential enteral source of erythropoietin
62. A unifying hypothesis for pathogenesis and prevention of necrotizing enterocolitis
63. Interleukin-1 beta inhibits the intestinal transport of [14C] 3-O-methylglucose in the rat
64. Interleukin-10-deficient mice develop chronic enterocolitis
65. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent
66. Long-term follow-up after bowel resection for necrotizing enterocolitis: Factors affecting outcome
67. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion
68. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birthweight
69. Trophic effects of interleukin-11 in rats with experimental short bowel syndrome
70. Breast milk and neonatal necrotising enterocolitis
71. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats
72. Molecular modeling of the GM-CSF and IL-3 receptor complexes
73. Human small intestinal epithelial cells secrete interleukin-7 and differentially express two different interleukin-7 mRNA transcripts: Implications for extrathymic T-cell differentiation
74. Interleukin-10 modulates ion transport in rat small intestine
75. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: Induction of interleukin 8 production and apoptosis after cell detachment
76. Tissue interleukin-1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats
77. Intestinal production of interleukin-1 alpha during endotoxemia in the mouse
78. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors
79. Hematopoietic regulators: Redundancy or subtlety?
80. Implications of the polyfunctionality of hemopoietic regulators
81. Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: Influence of colony-stimulating factors
82. The clonal proliferation of normal mouse hematopoietic cells: Enhancement and suppression by colony-stimulating factor combinations
83. 2
84. Sepsis and endotoxemia stimulate intestinal interleukin-6 production
85. Interleukin-6 and tumor necrosis factor production in an enterocyte cell model (Caco-2) during exposure to Escherichia coli
86. Colonic mucosal interleukin-6 in inflammatory bowel disease
87. Plasma interleukin-6 and tumour necrosis factor levels as predictors of disease severity and outcome in necrotizing enterocolitis
88. Thrombopoietin expression in normal and hypobaric hypoxia-induced thrombocytopenic rats
89. Intestinal epithelial cell regulation of macrophage and lymphocyte interleukin 10 expression
90. Necrotizing enterocolitis: The search for a unifying pathogenic theory leading to prevention
91. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis
92. Cytokine pleiotropy and redundancy: A view from the receptor
93. Granulocyte colony-stimulating factor
94. Structural aspects of cytokine/receptor interactions
95. Cytokine profiles of cultured microvascular endothelial cells from the human intestine
96. Granulocyte colony-stimulating factor for gastrointestinal perforation in patients with leukopenia
97. Erythropoietin to prevent and treat the anemia of prematurity
98. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis
99. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation
100. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor
101. GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha
102. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells
103. IL-6 production in human intestinal epithelial cells following stimulation with IL-1 beta is associated with activation of the transcription factor NF-kappa B
104. Suppression of T cell-mediated injury in human gut by interleukin 10: Role of matrix metalloproteinases
105. Interleukin-2 enhances the translocation of Escherichia coli from the intestines to other organs
106. Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation
107. Enhanced mucosal cytokine production in inflammatory bowel disease
108. Interleukin-1 beta is expressed predominantly by enterocytes in experimental colitis
109. Intestinal epithelial cells both express and respond to interleukin-15
110. Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor
111. Systemic bacteraemia following haemorrhagic shock in mice: Alleviation with oral Interleukin 6
112. Lipopolysaccharide induces synthesis of mouse colony-stimulating factor-1 in vivo
113. Granulocyte-macrophage colony-stimulating factor: Pleiotropic cytokine with potential clinical usefulness
114. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
115. Role of interleukin-1 in the pathogenesis of experimental shigellosis
116. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis
117. Effect of systemic interleukin-3 administration on epithelial cell proliferation in mouse intestine
118. Interleukin-11 improves survival and reduces bacterial translocation and bone marrow suppression in burned mice
119. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
120. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells
121. Intestinal microbial translocation: Immunologic consequences and effects of interleukin-4
122. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development
123. Identification and characterization of the rat intestinal epithelial cell (IEC-18) interleukin-1 receptor
124. Intracellular production of interleukin-18 in human epithelial-like cell lines is enhanced by hyperosmotic stress in vitro
125. Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network
126. Caco-2 cells express type I interleukin-1 receptors: Ligand binding enhances proliferation
127. Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease
128. Factors affecting Caco-2 intestinal epithelial cell interleukin-6 secretion
129. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes
130. Umbilical cord blood interleukin-6 levels and neonatal morbidity
131. The anti-inflammatory effect of an oral immunoglobulin (IgA-IgG) preparation and its possible relevance for the prevention of necrotizing enterocolitis
132. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism
133. Spontaneous expression of interleukin-2 in vivo in specific tissues of young mice
134. Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact